9351
|
|
|
Oxoeicosanoid receptor 1 |
GPCR, GPR170, TG1019 |
|
9352
|
|
|
Oxoglutarate receptor 1 |
CAON2, GPR80, GPR99, P2RY15, P2Y15, aKGR |
|
9353
|
|
|
Oxidoreductase NAD binding domain containing 1 |
RFTN1-AS1 |
|
9354
|
|
|
Oxidation resistance 1 |
CHEGDD, Nbla00307, TLDC3 |
Breast cancer, Cerebellar atrophy, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Congenital cerebellar hypoplasia, Hearing impairment, Insomnia, Intellectual developmental disorder, Neurotic disorder, Peripheral arterial disease |
9355
|
|
|
Oxidative stress responsive kinase 1 |
OSR1 |
|
9356
|
|
|
Oxytocin/neurophysin I prepropeptide |
OT, OT-NPI, OXT-NPI |
Anxiety disorder, Autism, Carcinoma, Colonic neoplasms, Major depressive disorder, Disseminated intravascular coagulation, Edema, Tonic-clonic epilepsy, Headache, Hyperkinesia, Hypertension, Hypotension, Mood disorder, Neurodevelopmental disorder, Prostatic disease, Schizophrenia, Seizures, Depression, Water intoxicationView all (4 more) |
9357
|
|
|
Oxytocin receptor |
OT-R, OTR |
Autism, Non-small-cell lung carcinoma, Cardiomyopathy, Chromosome 3p25 monosomy, Cognition disorder, Delirium, dementia, and cognitive disorders, Major depressive disorder, Disruptive, impulse control, and conduct disorders, Long qt syndrome, Hypertrophic cardiomyopathy, Joubert syndrome, Rippling muscle disease, Schizophrenia, Tubular aggregate myopathy, Depression |
9358
|
|
|
Purinergic receptor P2X 1 |
P2X1 |
|
9359
|
|
|
Purinergic receptor P2X 2 |
DFNA41, P2X2 |
|
9360
|
|
|
Purinergic receptor P2X 3 |
P2X3 |
|
